About the Authors
- Hui Cai
-
Affiliations Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America, Department of Thoracic Oncosurgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China
- Elena G. Chiorean
-
Affiliation Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
- Michael V. Chiorean
-
Affiliation Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
- Douglas K. Rex
-
Affiliation Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
- Bruce W. Robb
-
Affiliation Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
- Noah M. Hahn
-
Affiliations Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America, Hoosier Oncology Group, Indianapolis, Indiana, United States of America
- Ziyue Liu
-
Affiliation Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
- Patrick J. Loehrer
-
Affiliation Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
- Marietta L. Harrison
-
Affiliation Medicinal Chemistry and Molecular Pharmacology, Oncological Sciences Center, Purdue University Center for Cancer Research, West Lafayette, Indiana, United States of America
- Yan Xu
-
* E-mail: xu2@iupui.edu
Affiliation Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
Competing Interests
The authors have declared that no competing interests exist. The authors have filled a PCT Patent Application “PLA2 Activity as a Marker for Ovarian and Other Gynecologic Cancers” in 2011. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: YX. Performed the experiments: HC. Analyzed the data: HC ZL. Contributed reagents/materials/analysis tools: EGC MVC DKR BWR NMH PJL MLH. Wrote the paper: YX HC.